Non-acylated ghrelin counteracts the metabolic but not the neuroendocrine response to acylated ghrelin in humans
Non-acylated ghrelin counteracts the metabolic but not the neuroendocrine response to acylated ghrelin in humans
复制标题
DOI:
10.1210/jc.2003-031964
复制
发表时间:
2004-06-01
影响因子:
5.8
通讯作者:
Ghigo, E
中科院分区:
文献类型:
--
作者:
Broglio, F;Gottero, C;Ghigo, E
Ghrelin possesses strong GH-releasing activity but also other endocrine activities including stimulation of PRL and ACTH secretion, modulation of insulin secretion and glucose metabolism. It is assumed that the GH Secretagogue (GHS) receptor (GHS-R) 1a mediates ghrelin actions provided its acylation in Serine 3; in fact, acylated ghrelin only is able to exert endocrine activities. Acylated ghrelin (AG) is present in serum at a 2.5 fold lower concentration than unacylated ghrelin (UAG).UAG, however, is not biologically inactive;it shares with AG some non-endocrine actions like cardiovascular effects,modulation of cell proliferation and even some influence on adipogensis. Thus, these actions are likely to be mediated by GHS-R subtypes able to bind ghrelin independently of its acylation. In order to further clarify whether UAG is really devoid of any endocrine action, we studied the interaction of the combined administration of AG and UAG (1.0 mug/kg iv) in 6 normal young volunteers (age [mean +/- SE]: 25.4 +/- 1.2 yr; BMI: 22.3 +/- 1.0 kg/m(2)). As expected, AG induced marked increase (p < 0.01) in circulating GH, PRL, ACTH and cortisol levels. AG administration was also followed by a decrease in insulin levels (-285.4+/-64.8 mU*min/l; p